Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic approach for eosinophilic inflammatory disorders
Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps
Intraluminal release of citrullinated histone 3 from various cellular origins coincides with microvascular thrombosis in burn wounds